EUVIMEDEUVIMED entdecken
Open Access

US cancer deaths prevented due to survival improvements stratified by extent of disease, 2010-2019

Meredith S Shiels iD, Neal D Freedman iD, Anika T Haque iD, Amy Berrington de González iD, Stanley Lipkowitz iD, Douglas R Lowy iD, Ruth M Pfeiffer iD

JNCI: Journal of the National Cancer Institute · 01.10.2025 · 117 (10) · 2089-2095

DOI: 10.1093/jnci/djaf192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 16.07.2025. Verfasst von Meredith S Shiels und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural Research Program, NCI NIH HHS, Institute of Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Progress against cancer mortality has been driven by primary prevention, early detection, and cancer treatment. We estimated the number of cancer deaths that were avoided due to stage-specific improvements in cancer survival among patients diagnosed in 2010-2019 followed through 2020.

Methods

We used cancer incidence data from 17 Surveillance, Epidemiology, and End Results (SEER) cancer registries during 2004-2019. We estimated the number of cancer deaths prevented due to cancer- and stage-specific survival improvements (based on SEER summary stage) as the observed minus expected number of cancer deaths through 2020. We calculated the expected number of cancer deaths from estimated cumulative incidence models setting the calendar year effect to 2009.

Results

During 2010-2019, there were 3 310 270 incident cancers and 966 733 cancer deaths through 2020 in SEER-17. Improvements in stage-specific cancer survival resulted in a 4.7% (95% CI = −5.3% to −4.2%) decline in cancer deaths in females (22,874 fewer deaths) and a 4.4% (95% CI = −4.9% to −3.9%) decline in males (23 198 fewer deaths) in SEER-17 regions, corresponding to approximately 173 900 fewer cancer deaths in the full US population. The largest absolute declines were for lung and liver cancers, whereas the largest relative declines were observed for melanoma and leukemia. Cancer deaths prevented were not statistically significant for colorectal or prostate cancers. All statistical tests were 2-sided.

Conclusions

Stage-specific survival gains, reflecting treatment advances and improved access to cancer treatment from 2010 to 2019, resulted in an estimated 173 900 fewer cancer deaths among US cancer patients diagnosed during this time period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansFemaleMaleUnited StatesSEER ProgramIncidenceMiddle AgedAgedNeoplasm StagingSurvival RateAdultRegistries

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, United States.
  • Clinical Cancer Epidemiology Group, The Institute of Cancer Research, London, United Kingdom.
  • Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

ORCID-Profile: Meredith S Shiels, Neal D Freedman, Anika T Haque, Amy Berrington de González, Stanley Lipkowitz, Douglas R Lowy, Ruth M Pfeiffer

Förderung

  • Intramural Research Program
  • NCI NIH HHS
  • Institute of Cancer Research
  • National Cancer Institute

Zitieren

APA

Shiels, M. S., Freedman, N. D., Haque, A. T., Berrington de González, A., Lipkowitz, S., Lowy, D. R., & Pfeiffer, R. M. (2025). US cancer deaths prevented due to survival improvements stratified by extent of disease, 2010-2019. JNCI: Journal of the National Cancer Institute, 117(10), 2089-2095. https://doi.org/10.1093/jnci/djaf192

Vancouver

Shiels MS, Freedman ND, Haque AT, Berrington de González A, Lipkowitz S, Lowy DR, et al. US cancer deaths prevented due to survival improvements stratified by extent of disease, 2010-2019. JNCI: Journal of the National Cancer Institute. 2025;117(10):2089-2095. doi:10.1093/jnci/djaf192

BibTeX
@article{Shiels2025,
  author = {Shiels, Meredith S and Freedman, Neal D and Haque, Anika T and Berrington de González, Amy and Lipkowitz, Stanley and Lowy, Douglas R and Pfeiffer, Ruth M},
  title = {US cancer deaths prevented due to survival improvements stratified by extent of disease, 2010-2019},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  volume = {117},
  number = {10},
  pages = {2089--2095},
  doi = {10.1093/jnci/djaf192}
}
Kostenlos starten →